Tianjin Hankang Pharmaceutical Biotechnology Co. Ltd. is a high-tech enterprise that specializes in pharmaceutical R&D, production and sales. It holds independent intellectual property rights and was awarded the title of Tianjin Enterprise Technology Center in 2009. In 2014, its R&D center was rated as a Tianjin Enterprise Key Laboratory. It primarily focuses on researching new chemical drugs and has over 200 clinical approvals, 100 production approvals, 30 consistency evaluations, 25 API records and 2 API production bases. Hankang provides customers with one-stop integrated services for R&D, production, declaration and clinical practice.